IBDY ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs
This maturity-matched bond product invests in US investment-grade corporate bonds maturing in December 2033, combining the maturity characteristics of individual bonds with the diversification benefits of an ETF.
What Is This ETF?
It tracks the Bloomberg December 2033 Maturity Corporate Index and holds high-quality, US dollar-denominated corporate bonds maturing in 2033. Unlike a typical bond fund, it is liquidated on a set date and returns invested principal to shareholders.
It suits investors who want to raise funds for a specific point in time (the end of 2033) or who want to build a bond ladder with predictable cash flows.
It is a passively managed (index-tracking) ETF launched by iShares in 2023.
How Does It Invest?
| Item | Details |
|---|---|
| Tracked Index | Bloomberg December 2033 Maturity Corporate Index |
| Management Style | Passive (maturity-matching strategy) |
| Fund Maturity Date | Scheduled for December 15, 2033 |
| Distribution Frequency | Monthly |
| Total Expense Ratio | 0.10% |
The fund invests in investment-grade corporate bonds maturing between January 1 and December 15, 2033. As maturity approaches, the principal of the bonds it holds is converted into cash equivalents, and at final maturity the fund is liquidated and its net assets are distributed to shareholders.
- A target-date bond strategy with maturities concentrated in a specific year
- Better diversification and liquidity than buying individual bonds
Size and Costs
Assets under management (AUM) stand at $1.2B, and the expense ratio is 0.10% per year.
Because investors can benefit from holding bonds to maturity, uncertainty from interest rate fluctuations can be reduced, and a professionally constructed bond portfolio can be held at a low fee.
Performance and Trends
Short-term price swings can occur as interest rate policy changes, but because the maturity date is fixed, the fund's sensitivity to changes in market rates declines over time.
Alongside demand from individual investors saving for a specific goal, money continues to flow in from institutional investors building bond ladders who want to manage maturities precisely.
Strengths and Weaknesses
It is an efficient bond tool that offers predictable maturity returns and stability at the same time, but selling before maturity exposes investors to price fluctuation risk driven by market interest rates.
💪 Key Strengths
⚠️ Points to Watch
Alternative ETFs and Related Products
While LQD, shown in the table, tracks a broad corporate bond index with no maturity limit, IBDY has a clear end point in 2033. USHY and SPHY focus on high-yield bonds, so they carry more risk than IBDY. You can also combine it with funds of different maturities, such as IBDR (2027) or IBDZ (2035), to build your own bond portfolio.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| iShares iBoxx USD Investment Grade Corporate Bond ETF | $104.66 | +0.1% | $32.7B | 0.14% | 4.82% | -5.2% | |
| iShares Broad USD High Yield Corporate Bond ETF | $35.67 | -0.3% | $27.4B | 0.08% | 7.12% | -4.3% | |
| iShares Broad USD Investment Grade Corporate Bond ETF | $49.61 | +0.1% | $18.0B | 0.04% | 4.92% | -4.2% | |
| iShares iBoxx USD High Yield Corporate Bond ETF | $77.28 | -0.3% | $18.0B | 0.49% | 6.07% | -3.7% | |
| State Street SPDR Portfolio High Yield Bond ETF | $22.53 | -0.3% | $11.9B | 0.05% | 7.4% | -4.5% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| SPCX | Space Exploration Technologies Corp | 0.02% | $123.62 | -9.1% | $1.68T | - | - |
| AMGN | AMGEN Inc | 0.03% | $460.28 | -3.8% | $248.8B | 26.7 | 2.19% |
| AMZN | Amazon.com Inc | 0.02% | $260.21 | -2.2% | $2.81T | 21.0 | - |
| T | AT&T Inc | 0.02% | $21.82 | -0.1% | $147.0B | 11.8 | 5.09% |
| NVDA | NVIDIA Corp | 0.01% | $181.60 | -9.3% | $4.38T | 23.0 | 0.43% |
| ORCL | Oracle Corp | 0.01% | $115.16 | -6.9% | $348.2B | 18.1 | 1.71% |
| ABT | Abbott Laboratories | 0.01% | $113.60 | -1.6% | $196.6B | 41.9 | 2.29% |
Investor Checkpoints
IBDY is a specialized maturity-matched product that returns principal on a set date, so before investing, use the key checklist below to confirm that it matches the time you will need your funds.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 📅 Maturity Match | Confirm it aligns with your plan to recover funds at the end of 2033 | Keep monitoring |
| 📊 Credit Rating | Check whether the portfolio is built mainly of safe, investment-grade bonds | Excellent |
| 💸 Fee Level | Confirm a cost structure that is cheaper than similar bond ETFs | Very low |
| 📉 Interest Rate Sensitivity | Understand price volatility from interest rate changes during your holding period | Gradually declining |
If a company that issued the underlying corporate bonds goes bankrupt, there is a risk of principal loss. Investors should also note that just before the fund matures, the cash allocation rises and the expected return may fall.
It is a useful option for investors who want to build a lump sum needed around 2033 or who want stable retirement fund management. It is a core bond holding that combines the advantages of individual bonds with the convenience of an ETF.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.